Rosalind Advisors »

BioCryst Pharmaceuticals shares owned by Rosalind Advisors

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.8M 923k 9.52

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Xeris Pharmaceuticals (XERS)
Fennec Pharmaceuticals (FENC)
Savara (SVRA)
Vaxcyte (PCVX)
Eyepoint Pharmaceuticals Com New (EYPT)
X4 Pharmaceuticals Com New (XFOR)
Vor Biopharma Com New (VOR)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Celldex Therapeutics Com New (CLDX)
BioCryst Pharmaceuticals (BCRX)
Cybin Com New (HELP)
Cg Oncology (CGON)
Inspiremd (NSPR)

View all positions for Rosalind Advisors

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
RA Capital Management
Deerfield Management Company
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
TCG Crossover Management
Henderson Group
Perceptive Advisors
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Kynam Capital Management
Bank of America Corporation

View all funds holding BioCryst Pharmaceuticals